Intended use: For the quantitative determination of Unfractionated Heparin (UFH) and Low Molecular Weight Heparin (LMWH) activity in human citrated plasma on the IL Coagulation systems.
Principle: Based on a synthetic chromogenic substrate and on Factor Xa inactivation.
Measurement principle
Heparin + AT 
[Heparin • AT]
[Heparin • AT] + FXa (excess) [Heparin • AT • FXa] + FXa (residual)
S-2765 + FXa (residual) Peptide + pNA
Vials and volumes:
- 1 x 5 mL Factor Xa reagent (lyo)
- 1 x 4 mL Chromogenic substrate (S-2765) (lyo)
- 1 x 3 mL Antithrombin (lyo)
- 1 x 8 mL Buffer (Liq)
*ACL, ACL TOP, and HemosIL are trademarks of Instrumentation Laboratory.
Life Science Research
